4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-isoquinoline, 95.0%, 100g

1,3,3-Trimethyl-3,4-dihydroisoquinoline>98.0%(GC)(T)1g

Methyl 5-fluoro-2-methylnicotinate, 97%, 250mg

3-Fluoro-2-methoxybenzyl alcohol, 95.0%, 5g

5-methyl-4-phenyl-4H-1,2,4-triazole-3-thiol, 5g

Diethyl ethoxymethylene malonate, 98.0%, 50g

5-Methyl-2-(3-nitro-phenylamino)-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

Phosphinic acid, P-[3-[[(3,4-dichlorophenyl)methyl]amino]propyl]-P-(diethoxymethyl)-, 97%, 100mg

tert-Butyl 4-(propylamino)piperidine-1-carboxylate, 95.0%, 1g

1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID, 95.0%, 500mg

3-Chloro-4-iodoaniline, 95.0%, 10g

Cyclohexane, min 99.5%, for synthesis, 2.5L, glass packaging

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-[[(4-methylphenyl)diphenylmethyl]amino]-L-alanine, 98%, 1g